CoChat

The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress

Open access

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Introduction: Stress has been shown to be a tumor promoting factor. Both clinical and laboratory studies have shown that chronic stress is associated with tumor growth in several types of cancer. Corticotropin Releasing Factor (CRF) is the major hypothalamic mediator of stress, but is also expressed in peripheral tissues. Earlier studies have shown that peripheral CRF affects breast cancer cell proliferation and motility. The aim of the present study was to assess the significance of peripheral CRF on tumor growth as a mediator of the response to stress in vivo. Methods: For this purpose we used the 4T1 breast cancer cell line in cell culture and in vivo. Cells were treated with CRF in culture and gene specific arrays were performed to identify genes directly affected by CRF and involved in breast cancer cell growth. To assess the impact of peripheral CRF as a stress mediator in tumor growth, Balb/c mice were orthotopically injected with 4T1 cells in the mammary fat pad to induce breast tumors. Mice were subjected to repetitive immobilization stress as a model of chronic stress. To inhibit the action of CRF, the CRF antagonist antalarmin was injected intraperitoneally. Breast tissue samples were histologically analyzed and assessed for neoangiogenesis. Results: Array analysis revealed among other genes that CRF induced the expression of SMAD2 and β-catenin, genes involved in breast cancer cell proliferation and cytoskeletal changes associated with metastasis. Cell transfection and luciferase assays confirmed the role of CRF in WNT- β-catenin signaling. CRF induced 4T1 cell proliferation and augmented the TGF-β action on proliferation confirming its impact on TGFβ/SMAD2 signaling. In addition, CRF promoted actin reorganization and cell migration, suggesting a direct tumor-promoting action. Chronic stress augmented tumor growth in 4T1 breast tumor bearing mice and peripheral administration of the CRF antagonist antalarmin suppressed this effect. Moreover, antalarmin suppressed neoangiogenesis in 4T1 tumors in vivo. Conclusion: This is the first report demonstrating that peripheral CRF, at least in part, mediates the tumor-promoting effects of stress and implicates CRF in SMAD2 and β-catenin expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1476-4598-9-261

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Expression of CRF receptors in 4T1 cells. CRF receptor 1 and low levels of CRF receptor 2 were found expressed in 4T1 cells.- Con, negative control (non rt); + Con, positive control (mouse brain).
Figure 1 Expression of CRF receptors in 4T1 cells. CRF receptor 1 and low levels of CRF receptor 2 were found expressed in 4T1 cells.- Con, negative control (non rt); + Con, positive control (mouse brain).CC BY · PubMed Central
Figure 2 Effects of CRF on 4T1 cells proliferation. 4T1 cells were treated with different doses of CRF for 48 to 96 hours. CRF significantly induced proliferation of 4T1 cells, as measured by the MTT assay. The CRF1 antagonist Antalarmin reversed this effect. Data are expressed as the MEAN ± SEM of three independent experiments. * p < 0.05 compared to untreated control cells, + p < 0.05 compared to cells treated with 10-8M CRF and # p < 0.05 compared to cells treated with 10-9M CRF.
Figure 2 Effects of CRF on 4T1 cells proliferation. 4T1 cells were treated with different doses of CRF for 48 to 96 hours. CRF significantly induced proliferation of 4T1 cells, as measured by the MTT assay. The CRF1 antagonist Antalarmin reversed this effect. Data are expressed as the MEAN ± SEM of three independent experiments. * p < 0.05 compared to untreated control cells, + p < 0.05 compared to cells treated with 10-8M CRF and # p < 0.05 compared to cells treated with 10-9M CRF.CC BY · PubMed Central
Figure 3 Effects of CRF on the expression of molecules involved in tumor growth and metastasis. Gene-specific oligo microarrays for 113 genes known to be involved in tumor growth and metastasis were performed as described in Materials and methods. Effect of CRF on the expression of these molecules in 4T1 cells was analyzed. Mean expression of each gene was transformed into color intensity using the program TIGR MultiExperiment Viewer V4.5.1. The minimal value (green) and the maximum (red) were considered the limits (as noticed in bar above). The figure shows the molecules which expression was affected by CRF after 6 or 24 h of treatment: Bai1, Brain-specific angiogenesis inhibitor 1; Brms1, Breast cancer metastasis-suppressor 1; Ctnnb1, β-Catenin; Cdkn2a, Cyclin-dependent kinase inhibitor 2A; Smad2, MAD homolog 2; Hras1, Harvey rat sarcoma virus oncogene 1; Pten, Phosphatase and tensin homolog; Rb1, Retinoblastoma 1; Rhoc, Ras homolog gene family, member C.
Figure 3 Effects of CRF on the expression of molecules involved in tumor growth and metastasis. Gene-specific oligo microarrays for 113 genes known to be involved in tumor growth and metastasis were performed as described in Materials and methods. Effect of CRF on the expression of these molecules in 4T1 cells was analyzed. Mean expression of each gene was transformed into color intensity using the program TIGR MultiExperiment Viewer V4.5.1. The minimal value (green) and the maximum (red) were considered the limits (as noticed in bar above). The figure shows the molecules which expression was affected by CRF after 6 or 24 h of treatment: Bai1, Brain-specific angiogenesis inhibitor 1; Brms1, Breast cancer metastasis-suppressor 1; Ctnnb1, β-Catenin; Cdkn2a, Cyclin-dependent kinase inhibitor 2A; Smad2, MAD homolog 2; Hras1, Harvey rat sarcoma virus oncogene 1; Pten, Phosphatase and tensin homolog; Rb1, Retinoblastoma 1; Rhoc, Ras homolog gene family, member C.CC BY · PubMed Central
Figure 4 CRF induced the expression of β-catenin and SMAD2. Western blot analysis were performed as described in Materials and methods in order to asses the effect of CRF on β-catenin and SMAD2 expression at protein levels. CRF significantly induced the expression of β-catenin (A,B) at 4 and 6 h whereas the expression of SMAD2 (A, C) was significantly induced at 6, and 24 h. Data are expressed as MEAN ± SEM of five independent experiments. * p < 0.05 compared to untreated control. D. 4T1 cells were transfected with a luciferase construct containing a WNT-responsive element in which the complex of β-catenin and Tcf binds. Cells were stimulated with CRF and luciferase activity was measured in cell lysates 24 hours following stimulation. Data are expressed as MEAN ± SEM of three independent experiments (*p < 0.05). E. 4T1 cells were stimulated with TGFβ at 5 ng/ml in the presence or absence of CRF at 10-8M and proliferation was measured using the MTT assay. Data are expressed as MEAN ± SEM of three independent experiments. * p < 0.05 compared to TGFβ -only treated cells.
Figure 4 CRF induced the expression of β-catenin and SMAD2. Western blot analysis were performed as described in Materials and methods in order to asses the effect of CRF on β-catenin and SMAD2 expression at protein levels. CRF significantly induced the expression of β-catenin (A,B) at 4 and 6 h whereas the expression of SMAD2 (A, C) was significantly induced at 6, and 24 h. Data are expressed as MEAN ± SEM of five independent experiments. * p < 0.05 compared to untreated control. D. 4T1 cells were transfected with a luciferase construct containing a WNT-responsive element in which the complex of β-catenin and Tcf binds. Cells were stimulated with CRF and luciferase activity was measured in cell lysates 24 hours following stimulation. Data are expressed as MEAN ± SEM of three independent experiments (*p < 0.05). E. 4T1 cells were stimulated with TGFβ at 5 ng/ml in the presence or absence of CRF at 10-8M and proliferation was measured using the MTT assay. Data are expressed as MEAN ± SEM of three independent experiments. * p < 0.05 compared to TGFβ -only treated cells.CC BY · PubMed Central
Figure 5 Effect of CRF on actin polymerization in 4T1 cells. 4T1 cells were cultured on coverglass and stimulated with CRF for 2 or 4 h. After fixation, cells were permeabilized and stained for F-actin with rhodamine-conjugated phalloidin, as described in Materials and methods. CRF treatment resulted in a more intense actin staining compared to untreated control, especially after 4 h (A). Moreover, CRF treated 4T1 cells showed more pronounced actin stress fibers compared to untreated control (indicated by the arrow). Pictures are representatives of two independent experiments.
Figure 5 Effect of CRF on actin polymerization in 4T1 cells. 4T1 cells were cultured on coverglass and stimulated with CRF for 2 or 4 h. After fixation, cells were permeabilized and stained for F-actin with rhodamine-conjugated phalloidin, as described in Materials and methods. CRF treatment resulted in a more intense actin staining compared to untreated control, especially after 4 h (A). Moreover, CRF treated 4T1 cells showed more pronounced actin stress fibers compared to untreated control (indicated by the arrow). Pictures are representatives of two independent experiments.CC BY · PubMed Central
Figure 6 CRF promotes migration of 4T1 cells and expression of Cox-2. A. 4T1 cells were stimulated with 10-8M CRF or vehicle (control) in the presence or absence of Antalarmin and photographed at 0, 6, 12 and 24 hours after disruption of a small area of the cell layer. The remigration of the cells was quantified by measuring the distance at 3 at least different points of the gap of each image with the program Image J, and expressing the distance % of the average of the distance initially formed by the disruption (time 0). Results represent the average of three independent experiments. ++p < 0,01, +++p < 0.001 compared to control cells at the same time point; **p < 0,01; ***p < 0,001 compared to CRF-treated cells at the same time point. B. Expression of Cox-2 was measured in 4T1 stimulated cells by RT-PCR (upper panel) and real-time RT-PCR. Results represent the average of 3 independent experiments; ***p < 0,001 compared to control cells.
Figure 6 CRF promotes migration of 4T1 cells and expression of Cox-2. A. 4T1 cells were stimulated with 10-8M CRF or vehicle (control) in the presence or absence of Antalarmin and photographed at 0, 6, 12 and 24 hours after disruption of a small area of the cell layer. The remigration of the cells was quantified by measuring the distance at 3 at least different points of the gap of each image with the program Image J, and expressing the distance % of the average of the distance initially formed by the disruption (time 0). Results represent the average of three independent experiments. ++p < 0,01, +++p < 0.001 compared to control cells at the same time point; **p < 0,01; ***p < 0,001 compared to CRF-treated cells at the same time point. B. Expression of Cox-2 was measured in 4T1 stimulated cells by RT-PCR (upper panel) and real-time RT-PCR. Results represent the average of 3 independent experiments; ***p < 0,001 compared to control cells.CC BY · PubMed Central
Figure 7 Peripheral administration of antalarmin does not affect the HPA axis response. As described in Materials and methods, levels of corticosterone in serum were determined by RIA in the different groups of mice immediately after the last exposure to stress and on the 4th day of the interval that followed the last exposure to stress. Increased levels of corticosterone upon stress were not affected by the peripheral administration of antalarmin (A). Moreover, increased levels of corticosterone after the last exposure to stress were not affected by antalarmin either, and confirmed the development of chronic stress (B). Data are expressed as MEAN ± SEM. Five animals per group were used. * p < 0.05, compared to control not exposed to stress.
Figure 7 Peripheral administration of antalarmin does not affect the HPA axis response. As described in Materials and methods, levels of corticosterone in serum were determined by RIA in the different groups of mice immediately after the last exposure to stress and on the 4th day of the interval that followed the last exposure to stress. Increased levels of corticosterone upon stress were not affected by the peripheral administration of antalarmin (A). Moreover, increased levels of corticosterone after the last exposure to stress were not affected by antalarmin either, and confirmed the development of chronic stress (B). Data are expressed as MEAN ± SEM. Five animals per group were used. * p < 0.05, compared to control not exposed to stress.CC BY · PubMed Central
Figure 8 Peripheral CRF increased tumor growth and neoangiogenesis in vivo. An in vivo model of breast tumor and restraint stress was used and the percentage of tumor bearing mice and the extend of neoangiogenesis were determined as described in Materials and methods. (A) Peripheral administration of antalarmin diminished the stress-induced increase of the percentage of tumor bearing mice. (B) Representative pictures of the histological analysis. (C) The area of vascularization is increased in animals exposed to stress but this effect is abolished by the inhibition of peripheral CRF by the ip administration of antalarmin. ** p < 0.01 compared to control without tumor. # p < 0.05 compared to tumor-bearing mice injected with vehicle. + p < 0.05 compare to tumor-bearing mice exposed to stress and injected with vehicle.
Figure 8 Peripheral CRF increased tumor growth and neoangiogenesis in vivo. An in vivo model of breast tumor and restraint stress was used and the percentage of tumor bearing mice and the extend of neoangiogenesis were determined as described in Materials and methods. (A) Peripheral administration of antalarmin diminished the stress-induced increase of the percentage of tumor bearing mice. (B) Representative pictures of the histological analysis. (C) The area of vascularization is increased in animals exposed to stress but this effect is abolished by the inhibition of peripheral CRF by the ip administration of antalarmin. ** p < 0.01 compared to control without tumor. # p < 0.05 compared to tumor-bearing mice injected with vehicle. + p < 0.05 compare to tumor-bearing mice exposed to stress and injected with vehicle.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

See all 30

Metadata

Authors
Arranz, A., Venihaki, M., Mol, B., Androulidaki, A., Dermitzaki, E., Rassouli, O., Ripoll, J., Stathopoulos, E. N., Gomariz, R. P., Margioris, A. N., & Tsatsanis, C.
Affiliations
  • University of Crete (GR)
  • Foundation for Research and Technology Hellas (GR)
  • Universidad Complutense de Madrid (ES)
Corresponding author
  • Margioris, Andrew N
  • Tsatsanis, Christos
Venue
Molecular Cancer
Published
2010-09-27
Volume
9
Issue
1
Pages
261-261
ISSN
1476-4598 (ISSN-L)
OpenAlex
W2116390790
Cited by
30
References
56
Citations by year
2026: 3 · 2025: 1 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 2
FWCI
0.65
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
U.S. Department of Defense
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
corticotropin-releasing factor, chronic stress, tumor growth, breast cancer, 4T1 cells, antalarmin, Wnt/β-catenin signaling, Smad2, TGF-β/Smad2 signaling, cell proliferation, cell migration, actin reorganization, neoangiogenesis, restraint stress
MeSH terms
Animals, Breast Neoplasms, Cell Movement, Cell Survival, Corticotropin-Releasing Hormone, Female, Fluorescent Antibody Technique, Mice, Inbred BALB C, Pyrimidines, Pyrroles, Radioimmunoassay, Stress, Physiological, Blotting, Western, Gene Expression Regulation, Neoplastic, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress. https://app.cochat.ai/papers/10.1186/1476-4598-9-261
The paper
Arranz, A., Venihaki, M., Mol, B., Androulidaki, A., Dermitzaki, E., Rassouli, O., Ripoll, J., Stathopoulos, E. N., Gomariz, R. P., Margioris, A. N., & Tsatsanis, C. (2010). The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress. Molecular Cancer. https://doi.org/10.1186/1476-4598-9-261

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.